Literature DB >> 16275076

Pyrrolopyridazine MEK inhibitors.

Zhong Chen1, Soong-Hoon Kim, Stephanie A Barbosa, Tram Huynh, David R Tortolani, Kenneth J Leavitt, Donna D Wei, Veeraswamy Manne, Carolyn S Ricca, Johnni Gullo-Brown, Michael A Poss, Wayne Vaccaro, Mark E Salvati.   

Abstract

The synthesis and SAR of a series of pyrrolopyridazine MEK inhibitors are reported. Optimal activity was achieved by incorporation of a 4-phenoxyaniline substituent at C4 and an acylated amine at C6.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16275076     DOI: 10.1016/j.bmcl.2005.10.052

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  Ethyl 3-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[2,3-d]pyridazine-2-carboxyl-ate.

Authors:  Shi-Quan Chen; Kai Jiang; Shi-Fan Wang
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-01-09

2.  Synthesis, molecular modelling and anticancer evaluation of new pyrrolo[1,2-b]pyridazine and pyrrolo[2,1-a]phthalazine derivatives.

Authors:  Lacramioara Popovici; Roxana-Maria Amarandi; Ionel I Mangalagiu; Violeta Mangalagiu; Ramona Danac
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.